Analyst Reco. Zimmer Biomet Holdings, Inc. London S.E.

Equities

0QQD

US98956P1021

Market Closed - London S.E. Other stock markets 09:41:26 2021-01-29 am EST			5-day change	1st Jan Change
136.1 ^CHF	+6.20%		-.--%	-.--%

Jun. 20	Zimmer Biomet Holdings, Inc. Appoints Devdatt Kurdikar to its Board of Directors	CI
Jun. 12	Zimmer Biomet Enters Co-Marketing Deal With RevelAi Health	MT

Analyst Reco.

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Zimmer Biomet Holdings Insider Sold Shares Worth $1,474,582, According to a Recent SEC Filing	Jun. 04	MT
Barclays Adjusts Price Target on Zimmer Biomet to $125 From $130	May. 31	MT
Barclays Adjusts Price Target on Zimmer Biomet Holdings to $125 From $130	May. 31	MT
Argus Upgrades Zimmer Biomet to Buy From Hold With $150 Price Target	May. 21	MT
Raymond James Adjusts Price Target on Zimmer Biomet Holdings to $138 From $142	May. 03	MT
UBS Adjusts Price Target on Zimmer Biomet Holdings to $112 From $109, Maintains Sell Rating	May. 03	MT
Truist Adjusts Zimmer Biomet Holdings' PT to $130 From $137, Keeps Hold Rating	May. 03	MT
Bernstein Adjusts Price Target on Zimmer Biomet to $133 From $132	May. 03	MT
Jefferies Adjusts Price Target on Zimmer Biomet to $135 From $136	May. 03	MT
Citigroup Adjusts Price Target on Zimmer Biomet to $134 From $140	May. 03	MT
Morgan Stanley Adjusts Price Target on Zimmer Biomet to $130 From $135	May. 03	MT
Jefferies Adjusts Zimmer Biomet Price Target to $135 From $136	May. 03	MT
Citigroup Adjusts Zimmer Biomet Price Target to $134 From $140	May. 03	MT
Morgan Stanley Adjusts Zimmer Biomet Price Target to $130 From $135	May. 03	MT
Oppenheimer Adjusts Price Target on Zimmer Biomet Holdings to $155 From $150	May. 03	MT
BTIG Adjusts Price Target on Zimmer Biomet to $139 From $138, Keeps Buy Rating	May. 02	MT
Truist Securities Adjusts Zimmer Biomet Price Target to $137 From $135, Hold Rating Kept	Apr. 15	MT
Citigroup Raises Price Target on Zimmer Biomet to $140 From $134, Keeps Neutral Rating	Apr. 03	MT
UBS Adjusts Zimmer Biomet Price Target to $109 From $105, Maintains Sell Rating	Feb. 09	MT
Deutsche Bank Adjusts Zimmer Biomet Price Target to $140 From $147, Maintains Hold Rating	Feb. 09	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Analyst Reco. Zimmer Biomet Holdings, Inc. London S.E.

Equities

0QQD

US98956P1021

Analyst Reco.

Filters